Intravitreal bevacizumab for neovascular glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 5, 2009, Pages 453-458

  Vasudev, Deepta ^a   Blair, Michael P ^a   Galasso, John ^a   Kapur, Rashmi ^a   Vajaranant, Thasarat ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BRIMONIDINE; BUNAZOSIN; DIPIVEFRINE; DORZOLAMIDE; LATANOPROST; SANPILO; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; HUMAN; HYPERTENSION; INTRAOCULAR PRESSURE; LASER; NEOVASCULAR GLAUCOMA; PANRETINAL LASER; PATIENT ATTITUDE; PATIENT COMPLIANCE; RETINA DETACHMENT; RETINA ISCHEMIA; TREATMENT OUTCOME; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; GLAUCOMA, NEOVASCULAR; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; LASER COAGULATION; MIDDLE AGED; PATIENT COMPLIANCE; RETINA; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITREOUS BODY;

EID: 70350434088     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0036     Document Type: Article

References (28)

1. Brown, G.C., Magargal, L.E., Schachat, A., et al. Neovascular glaucoma. Etiologic considerations. Ophthalmology. 91:315-320, 1984.
2. Casey, R., and Li, W.W. Factors controlling ocular angiogenesis[review]. Am. J. Ophthalmol. 124:521-529, 1997.
3. Tripathi, R.C., Li, J., Tripathi, B.J., et al. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 105:232-237, 1998.
4. Sone, H., Okuda, Y., Kawakami, Y., et al. Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubeotic glaucoma is markedly elevated. Diabetes Care. 19:1306-1307, 1996.
5. Aiello, L.P., Avery, R.L., Arrigg, P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331:1480-1487, 1994.
6. Avery, R.L. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina. 26:352-354, 2006.
7. Mason JO, III, Albert MA, Jr, Mays, A., et al. Regression of neovascular iris vessels by intravitreal injection of bevacizumab. Retina. 26:839-841, 2006.
8. Bakri, S.J., Snyder, M.R., Reid, J.M., et al. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology. 114:855-859, 2007.
9. Ohnishi, Y., Ishibashi, T., and Sagawa, T. Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin. Exp. Ophthalmol. 232:199-204, 1994.
10. Magargal, L.E., Brown, G.C., Augsburger, J.J., et al. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology. 89:780-784, 1982.
11. Hayreh, S.S., Klugman, M.R., Podhajsky, P., et al. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study. Graefes Arch Clin. Exp. Ophthalmol. 228:281-296, 1990.
12. Caprioli, J., Strang, S.L., Spaeth, G.L., et al. Cyclocryotherapy in the treatment of advanced glaucoma. Ophthalmology. 92:947-954, 1985.
13. Krupin, T., Johnson, M.F., and Becker, B. Anterior segment ischemia after cyclocryotherapy. Am. J. Ophthalmol. 84:426-428, 1977.
14. Tsai, J.C., Feuer, W.J., Parrish, R.K., II, et al. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology. 102:887-892, 1995.
15. Lloyd, M.A., Heuer, D.K., Baerveldt, G., et al. Combined Molteno implantation and pars plana vitrectomy for neovascular glaucomas. Ophthalmology. 98:1401-1405, 1991.
16. L'Esperance, F.A., Jr., Mittl, R.N., and James, W.A., Jr. Carbon dioxide laser trabeculostomy for the treatment of neovascular glaucoma. Ophthalmology. 90:821-829, 1983.
17. Assaad, M.H., Baerveldt, G., and Rockwood, E.J. Glaucoma drainage devices: pros and cons. Curr. Opin. Ophthalmol. 34:349-352, 1999.
18. Molteno, A.C.B., and Haddad, P.J. The visual outcome in cases of neovascular glaucoma. Aust. N. Z. J. Ophthalmol. 13:329-335, 1985.
19. Mermoud, A., Salmon, J.F., Alexander, P., et al. Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology. 100:897-902, 1993.
20. Sidoti, P.A., Dunphy, T.R., Baerveldt, G., et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology. 102:1107-1118, 1995.
21. Silva Paula, J., Jorge, R., Alves Costa, R., et al. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol. Scand. 84:556-557, 2006.
22. Iliev, M.E., Domig, D., Wolf-Schnurrbursch, U., et al. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am. J. Ophthalmol. 142:1054-1056, 2006.
23. Chilov, M.N., Grigg, J.R., and Playfair, T.J. Bevacizumab (Avastin) for the treatment of neovascular glaucoma. Clin. Exp. Ophthalmol. 35:494-496, 2007.
24. Vatavuk, Z., Bencic, G., and Mandic, Z. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur. J. Ophthalmol. 17:269-271, 2007.
25. Davidorf, F.H., Mouser, J.G., and Derick, R.J. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina. 26:354-356, 2006.
26. Ehlers, J.P., Spirn, M.J., Lam, A., et al. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina. 28:698-702, 2008.
27. Wakabayashi, T., Oshima, Y., Sakaguchi, H., et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 115:1571-1580, 2008.
28. Wu, L., Martinez-Castellanos, M.A., Quiroz-Mercado, H., et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin® ): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch. Clin. Exp. Ophthalmol. 246(1):81-87, 2008.